Articles On Bioxyne (ASX:BXN)

Almost all ASX infant formula stocks recorded gains in April after plunging heavily in March. In April, the average infant formula stock gained 21 per cent and only two stocks finished the month in negative territory. In May, the list of wi...

In April the average infant formula stock gained 21 per cent and only two stocks finished the month in negative territory. Two of the top stocks were recent ASX debutantes Happy Valley Nutrition (ASX:HVM) and Nuchev (ASX:NUC), which gained...

Gastrointestinal diseases are among the most inconvenient types of illnesses to have, and not just because they may have you running to the loo every five minutes. The field covers many diseases like Irritable Bowel Syndrome (IBS), Crohn’s...

Following a solid December, January saw infant formula stocks retreat — but there was one stock which stood out. In a cruel twist of fate, it is not even a pure infant formula play but an infant formula supplement maker. Bioxyne (ASX:BXN) g...

It’s a bleak morning for ASX stocks in the tourism and China-focused sectors. A contravirus began in the Chinese city of Wuhan and while the city is now in lockdown mode, about 5 million people left beforehand due to the Lunar New Year holi...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

While it’s developed for the youngest and smallest, infant formula is actually big business, with Australia at the forefront. Here is a quick primer on everything you need to know about baby formula companies listed on the ASX. Over the las...

The Australian metals and mineral explorer, Greenland Minerals Limited (ASX: GGG) has been focusing on developing, what is positioned to be a future cornerstone to global rare earth supply, the Kvanefjeld Rare Earth Project in south-west Gr...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

On Stockhead today, the major oilies want to help Australia build a big hydrogen industry, the private eSports company that wants to disrupt the industry and Osteopore is on track to win the title of 2019’s best performing IPO. But first:  ...

Only three of the ASX’s dairy companies have seen their share price improve in the past month, as reporting season came to its end. HRL Holdings (ASX:HRL), Bioxyne (ASX:BXN) and Jatenergy (ASX:JAT) have all emerged from the period with thei...

The Australian dairy industry makes an important contribution to the economy as the country is a significant exporter of dairy products. However, the Australian dairy farm income can vary year to year due to the cost of farm inputs, the eff...

A 14 per cent recovery for dairy giant A2 Milk (ASX:A2M) during July saved the ASX’s dairy formula sector from another down month, while fellow big stocks Bellamy’s (ASX:BAL) and Synlait Milk (ASX:SM1) also gained. The sector has been slow...

In this article, we would be discussing four stocks with exposure to infant food products. On 20 June 2019, the Australian Bureau of Statistics (ABS) released the Australian Demographic Statistics, which enumerated that between December 201...

The 14 stocks that make up Stockhead’s infant formula list are coming off another slow month in June, as markets continue to assess the outlook for Chinese demand. The bigger names in the sector — A2 Milk (ASX: A2M), Bellamy’s (ASX: BAL) an...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...